Home › Cancro ovarico › Nebraska › Omaha
Studi clinici su Cancro ovarico a Omaha, NE
14 studi su Cancro ovarico cercano partecipanti presso sedi a Omaha e dintorni (entro circa 30 miglia). Apri uno studio per vedere chi può partecipare e come contattare il team.
Testo ufficiale dello studio (inglese)
Stai reclutando per uno studio? Mettilo in evidenza in cima alla pagina — $99 per 30 giorni →
177Lu-BetaBart in Patients With Relapsed/Refractory, Locally Advanced Inoperable, or Metastatic Solid Tumors
In reclutamentoFase 1/2
- Nebraska Cancer Specialists, Omaha
- XCancer, Omaha
A Study to Assess Adverse Events, Change in Disease Activity and How Intravenous (IV) ABBV901 Moves Through the Body Alone or in Combination With Other Anticancer Drugs in Adult Participants With Ovarian Cancer
In reclutamentoFase 1
- University Of Nebraska Medical Center /ID# 281020, Omaha
First-in-Human Study of ATX-295, an Oral Inhibitor of KIF18A, as Monotherapy and in Combination With Anticancer Therapy in Patients With Advanced or Metastatic Solid Tumors, Including Ovarian Cancer
In reclutamentoFase 1/2
- University of Nebraska Medical Center, Omaha
A Phase 1/2 Trial of TER-2013 in Patients With Solid Tumors Harboring AKT/PI3K/PTEN Pathway Alterations
In reclutamentoFase 1/2
- Nebraska Cancer Specialists, Omaha
A Clinical Trial of Sac-TMT in People With Non-HRD Positive Advanced Ovarian Cancer (MK-2870-021)
In reclutamentoFase 3
- Nebraska Methodist Hospital ( Site 0004), Omaha
- University Of Nebraska Medical Center ( Site 0035), Omaha
A Study of INCB123667 in Participants With Platinum-Resistant Ovarian Cancer With Cyclin E1 Overexpression
In reclutamentoFase 2
- Nebraska Methodist Hospital, Omaha
A Study to Evaluate the Efficacy and Safety of Sacituzumab Tirumotecan (MK-2870) Maintenance Treatment Versus Standard of Care in Participants With Platinum-sensitive Recurrent Ovarian Cancer (MK-2870-022/TroFuse-022/ENGOT-ov84/GOG-3103)
In reclutamentoFase 3
- Nebraska Methodist Hospital ( Site 0053), Omaha
Study of NTB-928 in R/R OC
In reclutamentoFase 1
- University of Nebraska Medical Center, Omaha
A Study to Compare Two Surgical Procedures in Individuals With BRCA1 Mutations to Assess Reduced Risk of Ovarian Cancer
In reclutamento
- Nebraska Cancer Specialists/Oncology Hematology West PC - MECC, Omaha
- Nebraska Methodist Hospital, Omaha
- Nebraska Medicine-Village Pointe, Omaha
- e altri 4
Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer
In reclutamentoFase 3
- Nebraska Cancer Specialists/Oncology Hematology West PC - MECC, Omaha
- Nebraska Methodist Hospital, Omaha
- Nebraska Medicine-Village Pointe, Omaha
- e altri 8
A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations
In reclutamentoFase 2
- Nebraska Cancer Specialists - Midwest Cancer Center - Legacy, Omaha
Lead-212 PSV359 Therapy for Patients With Solid Tumors
In reclutamentoFase 1/2
- Nebraska Cancer Specialists, Omaha
Integrated Cancer Repository for Cancer Research
In reclutamentoStudio osservazionaleVolontari sani benvenuti
- Methodist Estabrook Cancer Center, Omaha
- Nebraska Methodist Health System, Omaha
- University of Nebraska Medical Center, Omaha
- e altri 1
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
In reclutamentoStudio osservazionale
- Massive Bio SYNERGY-AI site, Omaha
Studi su Cancro ovarico in altre città
- Houston, TX89 studi
- New York City, NY69 studi
- Boston, MA61 studi
- Los Angeles, CA50 studi
- Nashville, TN49 studi
- Arlington, VA46 studi
- Philadelphia, PA44 studi
- Columbus, OH39 studi
- St. Louis, MO38 studi
- Chicago, IL36 studi
- San Antonio, TX31 studi
- Cleveland, OH30 studi
Altri studi a Omaha
- Cancro alla prostata27 studi
- Cancro del polmone non a piccole cellule24 studi
- Cancro al seno22 studi
- Cancro colorettale18 studi
- Cancro (tutti i tipi)18 studi
- Mieloma multiplo16 studi
- Linfoma non Hodgkin14 studi
- Cancro pancreatico14 studi
- Carcinoma a cellule squamose della testa e del collo13 studi
- Insufficienza cardiaca13 studi
- Cancro metastatico13 studi
- Cancro al rene (carcinoma a cellule renali)12 studi
Fonte: ClinicalTrials.gov, dati recuperati il 5 ott 2026. Ogni studio stabilisce i propri criteri di idoneità; è il team di ricerca a decidere chi può partecipare.